Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 30;38(7):830-835.
doi: 10.3969/j.issn.1673-4254.2018.07.10.

[Poly(ADP-ribose) polymerases-1 inhibitor MRL-45696 alleviates DNA damage after myocardial ischemia-reperfusion in diabetic rats]

[Article in Chinese]
Zhonghua Ji  1 , Lulu Zeng  1 , Yongjun Cheng  1 , Genqiang Liang  1
Affiliations

[Poly(ADP-ribose) polymerases-1 inhibitor MRL-45696 alleviates DNA damage after myocardial ischemia-reperfusion in diabetic rats]

[Article in Chinese]
Zhonghua Ji et al. Nan Fang Yi Ke Da Xue Xue Bao. .

Abstract
in English, Chinese

Objective: To study the protective effect of MRL-45696, an inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1), against DNA damage after myocardial ischemia/reperfusion (I/R) in diabetic rats.

Methods: Rat models of type 2 diabetes mellitus were established by high-fat feeding and a single peritoneal dose of streptozotocin. Forty diabetic rats were randomized equally into diabetic group, sham-operated group, sham-operated group with MRL-45696 treatment, I/R injury model group and I/R injury group with MRL-45696 treatment. The rats in MRL-45696-treated groups were subjected to daily intragastric administration of MRL-45696 (50 mg/kg) for 7 consecutive days, after which sham operation was performed or myocardial I/R injury was induced by ligation of the left anterior descending coronary artery for 30 min followed by reperfusion for 120 min. The range of myocardial infarction, plasma cardiac troponin I (cTnI), serum creatine kinase (CK), lactate dehydrogenase (LDH) activity, malondialdehyde (MDA), superoxide dismutase (SOD) activity, and cardiac myocyte apoptosis were detected. The levels of γ-H2AX, cleaved caspase-3, PARP-1, and PAR were detected with Western blotting, and the level of NAD was detected using colorimetry.

Results: The infarct size was significantly smaller in MRL-45696 treatment group than in I/R injury group (P < 0.05). In I/R model group, the levels of cTnI, CK, and LDH in the plasma or serum and MDA, γ-H2AX, cleaved caspase-3 and apoptotic rate in the cardiac myocytes were significantly higher than those in the other groups (P < 0.05), and SOD activity was significantly decreased (P < 0.05). Compared with I/R model group, the rats with MRL- 45696 treatment showed significantly decreased levels of cTnI, CK, LDH, MDA, γ-H2AX, cleaved caspase-3, PARP- 1, PAR expression and cell apoptosis with significantly increased levels of SOD and NAD (P < 0.05).

Conclusions: MRL-45696 can inhibit excessive activation of PARP-1, increase intracellular level of NAD and inhibit cardiac myocyte apoptosis to alleviate myocardial I/R-induced DNA damage and reduce myocardial infarct size in diabetic rats.

目的: 研究摄食二磷酸腺苷核糖聚合酶抑制剂MRL-45696是否减轻2型糖尿病大鼠心肌缺血/再灌注后DNA的损伤。

方法: 大鼠高糖高脂饲料喂食8周后腹腔注射链脲佐菌素（STZ）（30 mg/kg），构建2型糖尿病大鼠模型，选取2型糖尿病大鼠40只，随机分为糖尿病组（DM）、假手术组（S）、MRL-45696治疗+假手术组（NO）、缺血再灌注损伤模型组（MI/R）、MRL-45696治疗+缺血再灌注损伤组（MRL），每组各8只。灌胃给予2型糖尿病大鼠MRL-45696 (50 mg/kg·d)，1周后以大鼠冠状动脉左前降支结扎30 min再灌注120 min的方法制作心肌缺血再灌注损伤模型。检测大鼠血浆心肌肌钙蛋白Ⅰ（cTnI）、血清肌酸激酶（CK）、血清乳酸脱氢酶（LDH）活性和心肌梗死范围、细胞凋亡比例、丙二醛（MDA）、超氧化物歧化酶活性（SOD）。Western blot检测γ-H2AX、cleaved caspase-3、PARP-1、PAR；比色法检测大鼠心肌组织中烟酰胺腺嘌呤二核苷酸（NAD）水平（以NAD+/ NADH比例代表）。

结果: MRL组心肌梗死面积显著小于MI/R组（P < 0.05），MI/R组cTnI、CK、LDH、MDA、γ-H2AX、cleaved caspase-3表达水平及细胞凋亡较其它组显著升高（P < 0.05），而SOD水平明显降低（P < 0.05）；与MI/R组相比，MRL组大鼠cTnI、CK、LDH、MDA、γ-H2AX、cleaved caspase-3、PARP-1、PAR表达水平及细胞凋亡明显降低，SOD及NAD表达水平明显升高，差异有统计学意义（P < 0.05）。

结论: 糖尿病加重大鼠心肌细胞缺血再灌注后DNA损伤，MRL-45696可能通过抑制糖尿病大鼠PARP-1的过度激活，减轻心肌细胞缺血再灌注损伤，减少心肌梗死面积。

Keywords: DNA damage; MRL-45696; diabetic model; ischemia-reperfusion injury; poly(ADP-ribose) polymerase-1.

PubMed Disclaimer

Figures

1
1
伊文蓝-TTC法检测心肌梗死范围 Myocardial infarct size measured using Evans blue. The data are presented as the percentage of the infarct area in the ischemic area (Mean ± SD, n=8). DM: diabetes mellitus group. S: DM group with exposure but not ligation of the anterior descending branch of the coronary artery. NO: Sham operation group with MRL-45696 treatment. MI/R: DM group with myocardium ischemia-reperfusion injury. MRL: DM group with myocardium ischemia-reperfusion injury pretreated with MRL- 45696. *P < 0.05 vs DM, S and NO; #P < 0.05 vs MI/R.
2
2
TUNEL法检测大鼠心肌细胞凋亡比例 Myocardial cell apoptotic rates in rats detected by TUNEL assay. *P < 0.05 vs S and NO; #P < 0.05 vs MI/R.
3
3
Western Blot法检测大鼠心肌细胞γ-H2AX、cleaved caspase-3蛋白表达 Western blotting for detecting γ-H2AX and cleaved caspase-3 protein expression in the cardiac myocytes in diabetic rats.*P < 0.05 vs S and NO; #P < 0.05 vs MI/R.
4
4
Western blot法检测大鼠心肌细胞PARP-1、PAR蛋白表达 Western blotting for detecting PARP-1 and PAR protein expressions in the cardiac myocytes in diabetic rats. *P < 0.05 vs S; #P < 0.05 vs MI/R.
See this image and copyright information in PMC

References

    1. Dieuzeide G, Puchulu F, Sanabria H, et al. Cardiovascular effects of new non-insulinic anti-diabetes drugs. https://www.bioportfolio.com/resources/pmarticle/1797231/Combination-car.... Medicina (B Aires) 2018;78(3):185–93. [Dieuzeide G, Puchulu F, Sanabria H, et al. Cardiovascular effects of new non-insulinic anti-diabetes drugs[J]. Medicina (B Aires), 2018, 78(3): 185-93.] - PubMed
    1. 方 跃亭, 张 军能, 张 焕棕. 尿微量白蛋白与老年2型糖尿病合并缺血性心脏病关系的研究. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgxdyxzz2.... 中国医药指南. 2016;14(21):112–3. [方跃亭, 张军能, 张焕棕.尿微量白蛋白与老年2型糖尿病合并缺血性心脏病关系的研究[J].中国医药指南, 2016, 14(21): 112-3.]
    1. Lirk P, Verhamme C, Boeckh R, et al. Effects of early and late diabetic neuropathy on sciatic nerve block duration and neurotoxicity in Zucker diabetic fatty rats. Br JAnaesth. 2015;114(2):319–26. doi: 10.1093/bja/aeu270. [Lirk P, Verhamme C, Boeckh R, et al. Effects of early and late diabetic neuropathy on sciatic nerve block duration and neurotoxicity in Zucker diabetic fatty rats[J]. Br JAnaesth, 2015, 114(2): 319-26.] - DOI - PubMed
    1. Stratton IM, Cull CA, Adler AI, et al. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75) Diabetologia. 2006;49(8):1761–9. doi: 10.1007/s00125-006-0297-1. [Stratton IM, Cull CA, Adler AI, et al. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)[J]. Diabetologia, 2006, 49(8): 1761-9.] - DOI - PubMed
    1. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643–53. doi: 10.1056/NEJMoa052187. [Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes [J]. N Engl J Med, 2005, 353(25): 2643-53.] - DOI - PMC - PubMed

Publication types

LinkOut - more resources